Bioengineered soluble ACE2 for brain protection against SARS-CoV-2 infection

Österreich Nachrichten Nachrichten

Bioengineered soluble ACE2 for brain protection against SARS-CoV-2 infection
Österreich Neuesten Nachrichten,Österreich Schlagzeilen
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 44 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 71%

Bioengineered soluble ACE2 for brain protection against SARS-CoV-2 infection biorxivpreprint NorthwesternU ChariteBerlin UChicago brain SARSCoV2 ACE2 COVID19 coronavirus covid

By Bhavana KunkalikarDec 12 2022Reviewed by Danielle Ellis, B.Sc. In a recent study posted to the bioRxiv* preprint server, researchers compared the efficiency of bioengineered soluble angiotensin converting enzyme-2 concerning brain protection during coronavirus disease 2019 .

About the study In the present study, researchers examined the impact of an ACE2 618-DDC-ABD, a bioengineered soluble ACE2 protein with a sufficient duration of action and strong SARS-CoV-2 binding affinity. The team utilized k18-hACE2 mice, which expressed human ACE2 in its entirety and are sensitive to SARS-CoV-2 infection. Five to nine days after infection, animals with this viral load always succumb to the disease. The researchers examined the effects of pre-and post-treatment with the ACE2 618-DDC-ABD protein and compared intranasal and intraperitoneal delivery effects using distinct methodologies.

On day five, 0% of untreated and infected mice survived. Most mice that were administered ACE2 618-DDC-ABD post-viral inoculation experienced significant weight loss and deteriorating clinical score, while a few recovered and survived up to day 14.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

NewsMedical /  🏆 19. in UK

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

SARS-CoV-1 and SARS-CoV-2 spike proteins utilize different mechanisms to bind to ACE2SARS-CoV-1 and SARS-CoV-2 spike proteins utilize different mechanisms to bind to ACE2SARS-CoV-1 and SARS-CoV-2 spike proteins utilize different mechanisms to bind to ACE2 ACE2 Angiotensin Coronavirus COVID MERSCoV SARSCoV2 FrontMicrobiol UTEP HowardU
Weiterlesen »

What is the incidence of viral rebound after treatment with nirmatrelvir-ritonavir and molnupiravir?What is the incidence of viral rebound after treatment with nirmatrelvir-ritonavir and molnupiravir?What is the incidence of viral rebound after treatment with nirmatrelvir-ritonavir and molnupiravir? JAMANetworkOpen virus COVID19 coronavirus covid antivirals antiviral SARSCoV2
Weiterlesen »

Six-year-old with aggressive brain tumour among thousands to complete Santa DashSix-year-old with aggressive brain tumour among thousands to complete Santa DashCole Park was one of thousands of Santas who braved the cold to take part in the festive fun run. The six-year-old completed the popular Santa Dash in his wheelchair pushed by a team of supporters.
Weiterlesen »

Severe COVID-19 causes aging-like changes in the human brainSevere COVID-19 causes aging-like changes in the human brainSevere COVID-19 causes aging-like changes in the human brain Aging Brain Coronavirus Disease COVID Neurology harvardmed BIDMChealth BrighamWomens NatureAging
Weiterlesen »

Mum who needs urgent MRI for 'possible brain tumour' told she's too overweightMum who needs urgent MRI for 'possible brain tumour' told she's too overweight'Do they want me to die?' Mum who needs urgent MRI scan for 'possible brain tumour' told she's too overweight
Weiterlesen »



Render Time: 2025-03-12 08:42:17